About ImCare Biotech
ImCare Biotech is a private company based in Doylestown, Pennsylvania. It has reported $4,257,737 raised in five offerings on Form D since March 2020.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 5, 2023 | Jul 14, 2023 | $153,402fully sold | 1 | $153K | EquityRule 506(b) | Form D ↗ |
| Apr 6, 2022 | Apr 13, 2022 | $368,415fully sold | 1 | $368K | EquityRule 506(b) | Form D ↗ |
| Jul 15, 2021 | Jul 27, 2021 | $1,278,351fully sold | 1 | $1.2M | EquityRule 506(b) | Form D ↗ |
| Apr 20, 2021 | May 4, 2021 | $1,777,419fully sold | 4 | $444K | EquityRule 506(b) | Form D ↗ |
| Mar 5, 2020 | Mar 12, 2020 | $680,150fully sold | 3 | $226K | EquityRule 506(b) | Form D ↗ |
| Total, five offerings | $4,257,737 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on ImCare Biotech's Form D filed Jul 14, 2023.
FF
Frank Fischer
Director
ML
Matthew Lee
Director
AL
Aaron Lu
Executive officer and director
XP
Xuanyong Lu, PhD
President and director
FL
Felix Lu
Executive officer and director
Earlier filings also listed Lizhu Tang (director, last listed Mar 2020).